Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients
The programme is introduced in collaboration with MedGenome and Strand Life Sciences to expand access to molecular testing across…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
acute myeloid leukaemia
Servier India launches IDH1-targeted therapy Ivosidenib for AML and Cholangiocarcinoma
CDSCO approves Servier’s Ivosidenib for treatment of AML and Cholangiocarcinoma patients with IDH1 mutation
Vor Biopharma signs exclusive license pact with NCI for clinical-stage CD33 CAR-T
It is currently being evaluated in a multi-site Phase 1/2 clinical trial in children and young adults with relapsed or refractory…
Genentech announces full FDA approval for Venclexta combinations for acute myeloid leukaemia
The approval is primarily based on the results of two Phase III studies, VIALE-A and VIALE-C
US FDA approves Onureg (azacitidine tablets) to treat acute myeloid leukaemia
AML is one of the most common acute leukaemias in adults